Ginsenoside Rg4 is an orally active protopanaxatriol type ginsenoside. It can activate PI3K, AKT, and GSK-3β signaling, and inhibit ROS and inflammatory cytokine levels. It is used in research for inflammation, infection, and metabolic diseases like sepsis and lung inflammation.
- Activates PI3K, AKT, and GSK-3β signaling
- Inhibits ROS and inflammatory cytokine levels
- Used for research on inflammation, infection, and metabolic diseases
- Decreases expressions of toll-like receptor (TLR) 4 and TNF-α levels
- Increases cell viability via PI3K/AKT signaling activation
- Promotes hair-inductive properties of DP cells
- Inhibits inflammation and prolongs survival in sepsis models
- Attenuates inflammation in pulmonary inflammation models